MangoRx vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Willow beats MangoRx overall, scoring 8.2/10 vs 7.5/10. Choose MangoRx for users who want a multi-service telehealth platform covering . Choose Willow for users who want comprehensive clinical support with flexibili.

A side-by-side comparison of MangoRx and Willow covering pricing, scores, medication types, insurance, and more to help you decide.

MangoRx

#27 of 48

7.5/10

Multi-service telehealth platform offering compounded GLP-1 alongside other health services.

Visit MangoRx

Higher Rated

Willow

#8 of 48

8.2/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only — Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow

Feature	MangoRx	Willow
Our Score	7.5/10	8.2/10
Starting Price	$299/mo	$299/mo
Medication Type	Compounded	Compounded
Insurance Accepted	No	No
Best For	Users who want a multi-service telehealth platform covering weight loss and men's health	Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Ranking	#27	#8

Pros & Cons Compared

MangoRx

Pros

+Oral dissolving tablets exclusively — zero injections for any GLP-1 option
+Publicly traded on NASDAQ (MGRX) — SEC-required financial transparency that private competitors can't match
+Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment
+Free 100% online consultation with no video call required

Cons

−$299/mo for oral semaglutide is 2-3x the cost of injectable alternatives at $99-149/mo
−Early-stage public company with limited revenue — stock performance reflects financial uncertainty
−Only oral tablet format available — no injectable options if you want higher bioavailability

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Offers both injectable AND oral compounded semaglutide — one of few platforms with a daily oral tablet option
+$299/mo all-in for compounded semaglutide with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only — no brand-name Wegovy or Zepbound through the platform
−Tirzepatide pricing reaches $499-$524 at higher doses — starting dose is $399/mo
−Cash-pay only — no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024 — less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out MangoRx with a score of 8.2/10 vs 7.5/10. Choose MangoRx if you want: users who want a multi-service telehealth platform covering weight loss and men's health. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither MangoRx nor Willow feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Eden Health GLP-1→Read our full Eden Health GLP-1 review